Background: Recently, the Valve Academic Research Consortium (VARC)-3 criteria redefined bioprosthetic valve dysfunction (BVD) after transcatheter aortic valve implantation (TAVI). However, the rate of BVD is scarcely reported in current practice.
Aims: We aimed to evaluate the rate and predictors of BVD after TAVI based on the VARC-3 criteria.